Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Active not recruiting 2 Withdrawn 1 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14 Small Cell Lung Carcinoma 7 Carcinoma, Hepatocellular 7 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Biliary Tract Neoplasms 4 Rectal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Renal Cell 3 Stomach Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Bile Duct Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Unresectable Stage III NSCLC 1 Triple Negative Breast Neoplasms 1 Resectable Biliary Tract Cancer 1 Radiation Pneumonitis 1

Interventions

Fluorouracil 5 Radiotherapy 3 Paclitaxel 3 Leucovorin 3 Endoscopy 3 Cisplatin 3 Oxaliplatin 2 Neoadjuvant Therapy 2 Endoscopy, Digestive System 2 Endoscopic Mucosal Resection 2 Carboplatin 2 tremelimumab 1 rucaparib 1 rubitecan 1 durvalumab 1 Taxes 1 Surveys and Questionnaires 1 Ramucirumab 1 Radiation 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Microarray Analysis 1 Magnetic Resonance Imaging 1 Irinotecan 1 High-Throughput Screening Assays 1 Genetic Linkage 1 Epirubicin 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma Of Esophagus × durvalumab × Clear all

NCT04159974 2024-05-09

RICE

University of Cologne

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡